Armstrong says New Limit reprogrammed human cells in mice, eyes Phase I

What was said

"We've demonstrated successful reprogramming of at least one human cell type um in these humanized mouse models. We're now um testing that in human primate non-human primates. Um and then the first uh phase one clinical trial will be launching next year."

Armstrong says longevity start-up New Limit has successfully reprogrammed at least one human cell type in humanised mouse models. He says the company is now testing in non-human primates and plans a Phase I trial next year.